검색어 : 통합검색[Vaughn Margaret]
총 196건 중 196건 출력
, 16/20 페이지
-
151
- Health-Related Quality of Life (HRQOL) reporting in phase III randomized controlled trials (RCTs) of metastatic prostate adenocarcinoma (mPCa) and urothelial carcinoma (mUC).
- Jiang, Di Maria; Brundage, Michael Donald; Sweeney, Christopher; Fizazi, Karim; Bellmunt, Joaquim; Vaughn, David J.; Powles, Thomas; Perlis, Nathan; Kulkarni, Girish S.; Sridhar, Srikala S.; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; ; Division of Cancer Care and Epidemiology, Cancer Research Institute, Queen's University, Kingston, ON, Canada; ; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA; ; Gustave Roussy, University of Paris Sud, Villejuif, France; ; Dana-Farber Cancer Institute, Boston, MA; ; University of Pennsylvania, Philadelphia, PA; ; Barts Cancer Institute, Royal Free NHS trust, St. Bartholomew’s Hospital, London, United Kingdom; ; Department of Surgery, Division of Urology, University Health Network, Princess Margaret Cancer Centre, Toronto, ON, Canada; ; UHN Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada; ; The Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.37, 2019, pp.478-478)
-
152
- Minimal required PDT light dosimetry for nonmuscle invasive bladder cancer
- Lilge, Lothar; Wu, Jenny; Xu, Yiwen; Manalac, Angelica; Molenhuis, Daniel; Schwiegelshohn, Fynn; Vesselov, Leonid; Embree, Wayne; Nesbit, Michael; Betz, Vaughn; Mandel, Arkady; Jewett, Michael A. S.; Kulkarni, Girish S.; University Health Network , Princess Margaret Cancer Centre, Toronto, Ontario, Canada; University Health Network , Princess Margaret Cancer Centre, Toronto, Ontario, Canada; University Health Network , Princess Margaret Cancer Centre, Toronto, Ontario, Canada; University Health Network , Princess Margaret Cancer Centre, Toronto, Ontario, Canada; University of Toronto , Department of Medical Biophysics, Toronto, Ontario, Canada; University of Toronto , Department of Electrical and Computer Engineering, Toronto, Ontario, Canada; Theralase Technologies Inc. , Toronto, Ontario, Canada; Theralase Technologies Inc. , Toronto, Ontario, Canada; University of Toronto , Division of Urology, Department of Surgery, Toronto, Ontario, Canada; Universit; (Journal of biomedical optics, v.25, 2020, pp.068001)
-
153
- Minimal required PDT light dosimetry for nonmuscle invasive bladder cancer (Erratum)
- Lilge, Lothar; Wu, Jenny; Xu, Yiwen; Manalac, Angelica; Molenhuis, Daniel; Schwiegelshohn, Fynn; Vesselov, Leonid; Embree, Wayne; Nesbit, Michael; Betz, Vaughn; Mandel, Arkady; Jewett, Michael A. S.; Kulkarni, Girish S.; University Health Network , Princess Margaret Cancer Centre, Toronto, Ontario, Canada; University Health Network , Princess Margaret Cancer Centre, Toronto, Ontario, Canada; University Health Network , Princess Margaret Cancer Centre, Toronto, Ontario, Canada; University Health Network , Princess Margaret Cancer Centre, Toronto, Ontario, Canada; University of Toronto , Department of Medical Biophysics, Toronto, Ontario, Canada; University of Toronto , Department of Electrical and Computer Engineering, Toronto, Ontario, Canada; Theralase Technologies Inc. , Toronto, Ontario, Canada; Theralase Technologies Inc. , Toronto, Ontario, Canada; University of Toronto , Division of Urology, Department of Surgery, Toronto, Ontario, Canada; Universit; (Journal of biomedical optics, v.25, 2020, pp.069801)
-
154
- Chapter III. Maternal Sensitivity, Child Functional Level, and Attachment in Down Syndrome
- Atkinson, Leslie; Chisholm, Vivienne C.; Scott, Brian; Goldberg, Susan; Vaughn, Brian E.; Blackwell, Janis; Dickens, Susan; Tam, Frances; University of Toronto,; Queen Margaret College, Edinburgh, Scotland,; Private practice, Malaysia,; University of Toronto,; Auburn University,; North York School Board, Ontario, Canada,; Centre for Addiction and Mental Health, Toronto,Canada,; Pharmacia and Upjohn, Toronto, Canada.; (Monographs of the Society for Research in Child Development, v.64, 1999, pp.45-66)
-
155
- Light propagation within <small>N95</small> filtered face respirators: A simulation study for <small>UVC</small> decontamination
- Lilge, Lothar; Manalac, Angelica; Weersink, Madrigal; Schwiegelshohn, Fynn; Young‐ Schultz, Tanner; Abdalrhman, Abdallatif Satti; Wang, Chengjin; Ngan, Aldrich; Gu, Frank X.; Betz, Vaughn; Hofmann, Ron; Princess Margaret Cancer Centre University Health Network Toronto ON Canada; Princess Margaret Cancer Centre University Health Network Toronto ON Canada; Princess Margaret Cancer Centre University Health Network Toronto ON Canada; Department of Electrical and Computer Engineering University of Toronto Toronto ON Canada; Department of Electrical and Computer Engineering University of Toronto Toronto ON Canada; Department of Civil and Mineral Engineering University of Toronto Toronto ON Canada; Department of Civil and Mineral Engineering University of Toronto Toronto ON Canada; Department of Chemical Engineering and Applied Chemistry University of Toronto Toronto ON Canada; Department of Chemical Engineering and Applied Chemistry University of Toronto Toronto ON Canada; Department of Electrical and Computer Engineering University of Toronto Toronto ON Canada; Department of Civil and Mineral Engineering University of Toronto Toronto ON Canada; (Journal of biophotonics, v.13, 2020, pp.e202000232)
-
156
- Determination of Optical Properties and Photodynamic Threshold of Lung Tissue for Treatment Planning of <i>In Vivo</i> Lung Perfusion Assisted Photodynamic Therapy
- Ramadan, Khaled T.; McFadden, Christopher; Gomes, Bruno; Schwiegelshohn, Fynn; Ribeiro, Rafaela V.P.; Chan, Harley H.L.; Betz, Vaughn; Cypel, Marcelo; Lilge, Lothar; University of Toronto, Faculty of Medicine, Department of Surgery; University of Toronto, Faculty of Medicine, Department of Medical Biophysics; Princess Margaret Cancer Centre, University Health Network; University of Toronto, Faculty of Applied Science and Engineering, Department of Electrical and Computer Engineering; Princess Margaret Cancer Centre, University Health Network; Techna Institute, Guided Therapeutics Program, University Health Network; University of Toronto, Faculty of Applied Science and Engineering, Department of Electrical and Computer Engineering; University of Toronto, Faculty of Medicine, Department of Surgery; University of Toronto, Faculty of Medicine, Department of Medical Biophysics; (Photodiagnosis and photodynamic therapy, v.35, 2021, pp.102353)
-
157
- Abstract C051: Impact of population pharmacogenomics on cisplatin-induced neurotoxicities
- Nakshatri, Swetha; Dinh, Paul C.; Feldman, Darren R.; Hamilton, Robert J.; Fung, Chunkit; Vaughn, David J.; Kollmannsberger, Christian; Huddart, Robert; Einhorn, Lawrence H.; Cox, Nancy J.; Travis, Lois B.; Dolan, Eileen; University of Chicago, Chicago, IL, 1; Indiana University, Indianapolis, IN, 2; Memorial Sloan Kettering Cancer Center, New York, NY, 3; Princess Margaret Cancer Centre, Toronto, Canada, 4; University of Rochester Medical Center, Rochester, NY, 5; University of Pennsylvania, Philadelphia, PA, 6; University of British Columbia, Vancouver, Canada, 7; Royal Marsden Hospital, London, United Kingdom, 8; Indiana University, Indianapolis, IN, 2; Vanderbilt University Medical Center, Nashville, TN. 9; Indiana University, Indianapolis, IN, 2; University of Chicago, Chicago, IL, 1; (Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, v.33, 2024, pp.C051-C051)
-
158
- Cardiovascular disease (CVD) risk factors among cisplatin-treated testicular cancer survivors (TCS): A multicenter clinical study of U.S. and Canadian patients.
- Fung, Chunkit; Feldman, Darren Richard; Hamilton, Robert James; Case-Eads, Somer; Vaughn, David J.; Beard, Clair; Moore, Malcolm J.; Sahasrabudhe, Deepak M.; Brames, Mary J.; Fossa, Sophie D.; Sesso, Howard D.; Einhorn, Lawrence H.; Travis, Lois B.; Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY; Memorial Sloan Kettering Cancer Center, New York, NY; Division of Surgical Oncology, Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada; Indiana University, Indianapolis, IN; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA; Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, MA; Princess Margaret Cancer Centre, Toronto, ON, Canada; University of Rochester Wilmot Cancer Center, Rochester, NY; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN; Department of Oncology, Oslo University Hospital and University of Oslo, Oslo, Norway; Harvard T.H. Chan School of Public Health, Boston, MA; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN; University of Rochester School of Medicine and Dentistry, Rochester, NY; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.33, 2015, pp.391-391)
-
159
- Chronic health conditions (CHCs) following cisplatin-based chemotherapy (CHEM): A multi-institutional study of 680 testicular cancer survivors (TCS).
- Abu Zaid, Mohammad Issam; Sesso, Howard D.; Fung, Chunkit; Feldman, Darren Richard; Hamilton, Robert James; Vaughn, David J.; Beard, Clair; Moore, Malcolm J.; Sahasrabudhe, Deepak M.; Johnson, Eileen; Fossa, Sophie; Einhorn, Lawrence H.; Travis, Lois B.; Indiana University School of Medicine, Indianapolis, IN; Harvard Medical School, Division of Preventive Medicine, Boston, MA; Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY; Memorial Sloan Kettering Cancer Center, New York, NY; Division of Surgical Oncology, Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA; Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, MA; Princess Margaret Cancer Centre, Toronto, ON, Canada; University of Rochester Wilmot Cancer Center, Rochester, NY; University of Rochester School of Medicine and Dentistry, Rochester, NY; Oslo University Hospital, Oslo, Norway; Indiana University School of Medicine, Indianapolis, IN; University of Rochester School of Medicine and Dentistry, Rochester, NY; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.33, 2015, pp.9519-9519)
-
160
- Use of Medications for Treating Anxiety or Depression among Testicular Cancer Survivors: A Multi-Institutional Study
- ArdeshirRouhaniFard, Shirin; Dinh, Paul C.; Monahan, Patrick O.; Fossa, Sophie D.; Huddart, Robert; Fung, Chunkit; Song, Yiqing; Feldman, Darren R.; Hamilton, Robert J.; Vaughn, David J.; Martin, Neil E.; Kollmannsberger, Christian; Einhorn, Lawrence; Kroenke, Kurt; Travis, Lois B.; Indiana University, Indianapolis, Indiana.; Indiana University, Indianapolis, Indiana.; Indiana University, Indianapolis, Indiana.; Oslo University Hospital, Oslo, Norway.; Royal Marsden Hospital, London, United Kingdom.; University of Rochester Medical Center, Rochester, New York.; Indiana University, Indianapolis, Indiana.; Memorial Sloan Kettering Cancer Center, New York, New York.; Princess Margaret Cancer Center, Toronto, Canada.; University of Pennsylvania, Philadelphia, Pennsylvania.; Dana-Farber Cancer Institute, Boston, Massachusetts.; University of British Columbia, Vancouver, British Columbia, Canada.; Indiana University, Indianapolis, Indiana.; Indiana University, Indianapolis, Indiana.; Indiana University, Indianapolis, Indiana.; (Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, v.30, 2021, pp.1129-1138)
QUICK MENU
